HCSGD entry for NF1
1. General information
Official gene symbol | NF1 |
---|---|
Entrez ID | 4763 |
Gene full name | neurofibromin 1 |
Other gene symbols | NFNS VRNF WSS |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000165 | MAPK cascade | IEA ISS | biological_process |
GO:0001649 | Osteoblast differentiation | IEA ISS | biological_process |
GO:0001656 | Metanephros development | IEA ISS | biological_process |
GO:0001666 | Response to hypoxia | IEA ISS | biological_process |
GO:0001889 | Liver development | IEA ISS | biological_process |
GO:0001937 | Negative regulation of endothelial cell proliferation | IEA IMP | biological_process |
GO:0001938 | Positive regulation of endothelial cell proliferation | IEA | biological_process |
GO:0001952 | Regulation of cell-matrix adhesion | ISS | biological_process |
GO:0001953 | Negative regulation of cell-matrix adhesion | IEA | biological_process |
GO:0005099 | Ras GTPase activator activity | IDA IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005622 | Intracellular | IEA | cellular_component |
GO:0005634 | Nucleus | ISS | cellular_component |
GO:0005737 | Cytoplasm | IBA IEA ISS | cellular_component |
GO:0006469 | Negative regulation of protein kinase activity | ISS | biological_process |
GO:0007154 | Cell communication | ISS | biological_process |
GO:0007165 | Signal transduction | IEA | biological_process |
GO:0007265 | Ras protein signal transduction | IEA ISS | biological_process |
GO:0007406 | Negative regulation of neuroblast proliferation | IEA ISS | biological_process |
GO:0007420 | Brain development | ISS | biological_process |
GO:0007422 | Peripheral nervous system development | ISS | biological_process |
GO:0007507 | Heart development | IEA ISS | biological_process |
GO:0007519 | Skeletal muscle tissue development | IEA | biological_process |
GO:0008429 | Phosphatidylethanolamine binding | IDA | molecular_function |
GO:0008542 | Visual learning | IEA ISS | biological_process |
GO:0008625 | Extrinsic apoptotic signaling pathway via death domain receptors | IEA | biological_process |
GO:0014044 | Schwann cell development | ISS | biological_process |
GO:0014065 | Phosphatidylinositol 3-kinase signaling | IEA ISS | biological_process |
GO:0016525 | Negative regulation of angiogenesis | IEA | biological_process |
GO:0021510 | Spinal cord development | IEA ISS | biological_process |
GO:0021897 | Forebrain astrocyte development | IEA ISS | biological_process |
GO:0021915 | Neural tube development | IEA | biological_process |
GO:0021987 | Cerebral cortex development | IEA ISS | biological_process |
GO:0022011 | Myelination in peripheral nervous system | IEA ISS | biological_process |
GO:0030036 | Actin cytoskeleton organization | IEA ISS | biological_process |
GO:0030198 | Extracellular matrix organization | ISS | biological_process |
GO:0030199 | Collagen fibril organization | IEA ISS | biological_process |
GO:0030325 | Adrenal gland development | IEA ISS | biological_process |
GO:0030336 | Negative regulation of cell migration | IEA IMP | biological_process |
GO:0030424 | Axon | IDA | cellular_component |
GO:0030425 | Dendrite | IDA | cellular_component |
GO:0031210 | Phosphatidylcholine binding | IDA | molecular_function |
GO:0031235 | Intrinsic component of the cytoplasmic side of the plasma membrane | IBA | cellular_component |
GO:0032228 | Regulation of synaptic transmission, GABAergic | IEA | biological_process |
GO:0032318 | Regulation of Ras GTPase activity | IMP | biological_process |
GO:0032320 | Positive regulation of Ras GTPase activity | IDA IMP ISS | biological_process |
GO:0035021 | Negative regulation of Rac protein signal transduction | IEA | biological_process |
GO:0042060 | Wound healing | IEA ISS | biological_process |
GO:0042992 | Negative regulation of transcription factor import into nucleus | IEA ISS | biological_process |
GO:0043065 | Positive regulation of apoptotic process | ISS | biological_process |
GO:0043407 | Negative regulation of MAP kinase activity | IEA ISS | biological_process |
GO:0043409 | Negative regulation of MAPK cascade | IMP ISS | biological_process |
GO:0043473 | Pigmentation | IEA ISS | biological_process |
GO:0043525 | Positive regulation of neuron apoptotic process | IEA ISS | biological_process |
GO:0043535 | Regulation of blood vessel endothelial cell migration | IMP | biological_process |
GO:0045124 | Regulation of bone resorption | IEA ISS | biological_process |
GO:0045671 | Negative regulation of osteoclast differentiation | IEA | biological_process |
GO:0045685 | Regulation of glial cell differentiation | ISS | biological_process |
GO:0045762 | Positive regulation of adenylate cyclase activity | IEA ISS | biological_process |
GO:0045765 | Regulation of angiogenesis | IMP | biological_process |
GO:0046580 | Negative regulation of Ras protein signal transduction | IBA IEA | biological_process |
GO:0046929 | Negative regulation of neurotransmitter secretion | IEA | biological_process |
GO:0048147 | Negative regulation of fibroblast proliferation | IEA ISS | biological_process |
GO:0048169 | Regulation of long-term neuronal synaptic plasticity | IEA | biological_process |
GO:0048485 | Sympathetic nervous system development | IEA ISS | biological_process |
GO:0048593 | Camera-type eye morphogenesis | IEA ISS | biological_process |
GO:0048712 | Negative regulation of astrocyte differentiation | IEA | biological_process |
GO:0048715 | Negative regulation of oligodendrocyte differentiation | IEA ISS | biological_process |
GO:0048745 | Smooth muscle tissue development | IEA ISS | biological_process |
GO:0048844 | Artery morphogenesis | IEA ISS | biological_process |
GO:0048853 | Forebrain morphogenesis | IEA ISS | biological_process |
GO:0050890 | Cognition | IMP | biological_process |
GO:1902043 | Positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | IEA | biological_process |
GO:2001241 | Positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.3569985411 | 0.9511380305 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.1043154227 |
GSE13712_SHEAR | Up | 0.1632581706 |
GSE13712_STATIC | Up | 0.1472447427 |
GSE19018 | Up | 0.1728364874 |
GSE19899_A1 | Up | 0.0747465454 |
GSE19899_A2 | Up | 0.1764948561 |
PubMed_21979375_A1 | Up | 0.1712939725 |
PubMed_21979375_A2 | Up | 0.2657988237 |
GSE35957 | Up | 0.0369049036 |
GSE36640 | Down | -0.0415005985 |
GSE54402 | Up | 0.2073816077 |
GSE9593 | Up | 0.0520915023 |
GSE43922 | Up | 0.0071825622 |
GSE24585 | Up | 0.0888339838 |
GSE37065 | Up | 0.1087005409 |
GSE28863_A1 | Up | 0.1259975745 |
GSE28863_A2 | Down | -0.0619604124 |
GSE28863_A3 | Down | -0.1378590592 |
GSE28863_A4 | Up | 0.0572051703 |
GSE48662 | Up | 0.1836893861 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-10b-5p | MIMAT0000254 | MIRT005504 | GFP reporter assay//Luciferase reporter assay//Microarray//qRT-PCR | Functional MTI | 20550523 |
hsa-miR-370-3p | MIMAT0000722 | MIRT007052 | Luciferase reporter assay | Functional MTI | 23077663 |
hsa-miR-20a-3p | MIMAT0004493 | MIRT038968 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-193b-3p | MIMAT0002819 | MIRT041324 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-let-7e-5p | MIMAT0000066 | MIRT051457 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 4 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
25220407 | TGF-beta/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence |
25220407 | We previously reported formation of novel NF1/Smad transcription repressor complexes in growth-arrested fibroblasts |
25220407 | Mechanistically, binding of the NF1/Smad complexes to the NF1-dependent repressor elements in the ANT2 gene promoter repressed ANT2 expression |
25220407 | Together, our data show that TGF-beta-mediated suppression of ANT2 through NF1/Smad4 complexes contributes to oxidative stress and DNA damage during induction of cellular senescence |
23145129 | Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis |
23145129 | The loss of NFl from the endothelium is embryonically lethal in mouse developmental models, however little is known regarding the molecular regulation by NF1 in endothelium |
23145129 | We investigated the consequences of losing NF1 expression on the function of endothelial cells using shRNA |
23145129 | The loss of NF1 was sufficient to elevate levels of active Ras under non-stimulated conditions |
23145129 | Cells knocked down in NF1 expression exhibited no cellular senescence |
23145129 | We find the changes induced by the loss of NF1 could be mitigated by co-expression of the GAP-related domain of NF1 implicating Ras regulation in these effects |
23145129 | Using doxycycline-inducible shRNA, targeting NF1, we find that the morphogenic changes are reversible |
23145129 | Similarly, in fully differentiated and stable vascular-like structures, the silencing of NF1 results in the appearance of abnormal vascular structures |
23145129 | These data provide a detailed analysis of the molecular and functional consequences of NF1 loss in human endothelial cells |
16893911 | Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells |
16893911 | Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1, a pandemic autosomal dominant genetic disorder with an incidence of 1:3000 |
16893911 | Individuals with NF1 have a variety of malignant and non-malignant manifestations, including skeletal manifestations, such as osteoporosis, scoliosis and short statures |
16893911 | However, the mechanism(s) underlying the osseous manifestations in NF1 are poorly understood |
16893911 | In the present study, utilizing Nf1 haploinsufficient (+/-) mice, we demonstrate that Nf1+/- mesenchymal stem/progenitor cells (MSPC) have increased proliferation and colony forming unit-fibroblast (CFU-F) capacity compared with wild-type (WT) MSPC |
16893911 | Nf1+/- MSPC also have fewer senescent cells and have a significantly higher telomerase activity compared with WT MSPC |
16893911 | Nf1+/- MSPC have impaired osteoblast differentiation as determined by alkaline phosphatase staining, and confirmed by single CFU-F replating assays |
16893911 | The impaired osteoblast differentiation in Nf1+/- MSPC is consistent with the reduced expression of osteoblast markers at the mRNA level, including osteocalcin and osteonectin |
16893911 | Importantly, re-expression of the full-length NF1 GTPase activating related domain (NF1 GAP-related domain) is sufficient to restore the impaired osteoblast differentiation in Nf1+/- MSPC |
16893911 | Taken together, our results suggest that neurofibromin plays a crucial role in modulating MSPC differentiation into osteoblasts, and the defect in osteoblast differentiation may contribute at least in part to the osseous abnormalities seen in individuals with NF1 |
11213969 | OBJECT: Patients with neurofibromatosis Type 1 (NF1) have a predisposition to development of a variety of benign and malignant tumors including neurofibromas, astrocytomas, pheochromocytomas, and malignant peripheral nerve sheath tumors |
11213969 | The availability of an astrocytoma cell line derived from NF1 would be useful in studies in which sporadic astrocytomas could be compared with NF1-derived astrocytomas |
11213969 | In this article the authors describe a novel astrocytoma cell line, TM-31, that they established from a tumor removed in a 42-year-old woman with NF1 |
11213969 | The TM-31 cells display little neurofibromin expression when subjected to immunoblotting, indicating that there is an NF1 gene mutation |
11213969 | CONCLUSIONS: The TM-31 cell line is an immortalized astrocytoma cell line derived from a tumor obtained in a patient with NF1 |
Entries Per Page
Displaying Page of